Clinical Feasibility Study of Gold Nanoparticles as Theragnostic Agents for Precision Radiotherapy.

Biomedicines · 2022 · PMC9139134 · PMID 35625950

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The CN factor was parameterized, resulting in CN100 values of 0.6525 with nanoparticles versus 0.3422 without them, which would give highly significant clinical differences (see Table 1 ). 3.4.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.